A/S Novo Nordisk (manufacturer of unpackaged product, filling, primary packaging, quality control and responsible for batch release of final product; manufacturer for assembly, labeling and packaging, secondary packaging)

The drug is used to treat inadequately controlled type 2 diabetes mellitus in adults, adolescents, and children aged 10 years and older. It can be used as monotherapy (if metformin is not suitable) or in combination with other diabetes treatments.

Dosage form: solution for injection

ATC: A10BJ02